We are live on
!
Find out more
BP
Ballentine Partners Portfolio holdings
AUM
$8.18B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.18%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.02B
AUM Growth
+$153M
(+18%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
12.36%
Top 10 Holdings %
Top 10 Hldgs %
68.46%
Holding
159
New
8
Increased
52
Reduced
67
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EIGI
Endurance International Group Holdings, Inc.
EIGI
|
+$111M |
| 2 |
Ocular Therapeutix
OCUL
|
+$6.9M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.54M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$5.03M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.65M |
| 2 |
SAPE
SAPIENT CORP
SAPE
|
+$2.27M |
| 3 |
Novartis
NVS
|
+$1.09M |
| 4 |
iShares MSCI Pacific ex Japan ETF
EPP
|
+$743K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$711K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.56% |
| 2 | Healthcare | 2.01% |
| 3 | Financials | 1.11% |
| 4 | Industrials | 0.86% |
| 5 | Consumer Staples | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Citigroup
C
$222B
| $631K | 0.06% |
12,240
-211
| -2% | -$10.7K |
|
77
Oracle
ORCL
$367B
| $629K | 0.06% |
14,567
+1,281
| +10% | +$55.5K |
|
|
SRCL
78
DELISTED
Stericycle Inc
SRCL
| $621K | 0.06% |
4,420
-1,222
| -22% | -$165K |
|
79
Gilead Sciences
GILD
$163B
| $609K | 0.06% |
6,206
-195
| -3% | -$19.8K |
|
80
3M
MMM
$90.8B
| $601K | 0.06% |
4,355
+507
| +13% | +$69.9K |
|
81
Automatic Data Processing
ADP
$105B
| $592K | 0.06% |
6,910
+775
| +13% | +$66.7K |
|
82
CVS Health
CVS
$134B
| $543K | 0.05% |
5,261
+1,291
| +33% | +$131K |
|
83
Verizon
VZ
$193B
| $540K | 0.05% |
11,104
-462
| -4% | -$22.3K |
|
84
Thermo Fisher Scientific
TMO
$214B
| $532K | 0.05% |
3,961
-43
| -1% | -$5.54K |
|
85
State Street SPDR S&P Dividend ETF
SDY
$21.8B
| $510K | 0.05% |
6,520
+1,500
| +30% | +$118K |
|
86
Amazon
AMZN
$2.53T
| $509K | 0.05% |
27,380
-180
| -0.7% | -$3.17K |
|
|
ESRX
87
DELISTED
Express Scripts Holding Company
ESRX
| $506K | 0.05% |
5,824
+279
| +5% | +$23.4K |
|
88
McDonald's
MCD
$191B
| $499K | 0.05% |
5,122
+47
| +0.9% | +$4.46K |
|
89
Biogen
BIIB
$30.7B
| $488K | 0.05% |
1,157
-10
| -0.9% | -$3.94K |
|
90
Invesco QQQ Trust
QQQ
$450B
| $486K | 0.05% |
4,598
| – | – |
|
91
Union Pacific
UNP
$172B
| $471K | 0.05% |
4,343
-100
| -2% | -$11.7K |
|
|
BNY
92
Bank of New York Mellon
BNY
$106B
| $469K | 0.05% |
11,640
-716
| -6% | -$27.9K |
|
93
Nike
NKE
$62.7B
| $467K | 0.05% |
9,312
-128
| -1% | -$6.12K |
|
94
US Bancorp
USB
$98B
| $466K | 0.05% |
10,656
+619
| +6% | +$27.1K |
|
95
Analog Devices
ADI
$179B
| $460K | 0.05% |
7,309
+294
| +4% | +$16.7K |
|
96
Stryker
SYK
$133B
| $460K | 0.05% |
4,984
+166
| +3% | +$15.5K |
|
97
Vanguard Morningstar Growth ETF
VUG
$218B
| $454K | 0.04% |
26,040
| – | – |
|
98
Bank of America
BAC
$433B
| $446K | 0.04% |
28,963
-1,148
| -4% | -$18.4K |
|
99
RTX Corp
RTX
$289B
| $441K | 0.04% |
5,992
+233
| +4% | +$17.4K |
|
100
Amgen
AMGN
$209B
| $440K | 0.04% |
2,751
-116
| -4% | -$18.3K |
|
Similar funds
LGF
OC
CCM
CL
WJWM
WA
CCM
AIM
Ballentine Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Ballentine Partners held 159 positions worth $1.02B, up 18% from $866M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Ballentine Partners deployed $126M of net new capital in Q1 2015, opening 8 new positions and adding to 52 existing holdings. Its largest new stake was Endurance International Group Holdings, Inc.: 6,048,805 shares worth $115M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 1.4% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $2.65M trimmed.
- Ballentine Partners's largest Q1 2015 buy was Endurance International Group Holdings, Inc.: 6,048,805 shares worth $115M.
- Ballentine Partners added most to iShares Core MSCI Emerging Markets ETF in Q1 2015, an estimated $6.54M increase.
- Ballentine Partners's biggest Q1 2015 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $2.65M.
- Ballentine Partners fully exited SAPIENT CORP in Q1 2015, selling an estimated $2.27M.
- Ballentine Partners's ten largest holdings make up 68% of its $1.02B portfolio in Q1 2015.
- Ballentine Partners opened 8 new positions and closed 6 in Q1 2015.
- Ballentine Partners's portfolio value rose 18% quarter-over-quarter to $1.02B.
Based on Ballentine Partners's 13F filing for Q1 2015, filed 12 May 2015.